Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells.
about
Mechanisms of multistep carcinogenesis and carcinogen risk assessmentMetabolic and cellular analysis of alopecia in vitamin D receptor knockout miceAsporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast CancerThe ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesisCDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells.Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors.v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis.Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells.Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint.Intrinsic optical biomarkers associated with the invasive potential of tumor cells in engineered tissue models.Opposing roles for calcineurin and ATF3 in squamous skin cancer.Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence.Aberrant expression and function of gap junctions during carcinogenesis.Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes.Dermal fibroblasts tumor suppression of ras-transformed keratinocytes is associated with induction of squamous cell differentiationCellular aging is a critical determinant of primary cell resistance to v-src transformation.The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia.Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiationRetroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia.Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein.Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins.Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development.Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer.The tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins.Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environmentp19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytesCollateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.Targeting the Microenvironment in High Grade Serous Ovarian Cancer
P2860
Q24554416-A9ECE563-332D-471D-A9B1-9CAD81C39079Q28362793-C6463F98-98EE-405B-AC41-2567AECE137BQ28547683-3B6E9D05-E4F9-44D3-855B-6BD3968296ECQ28587433-88AD3189-D74A-40A2-8EC6-D2B4498CF2ABQ30660784-F01BD2F1-4ACB-4F5B-B0CD-B3E7319C3E01Q33589833-188A4C6C-1198-4E5D-8EFF-E853ABE3493DQ33759032-A4DE5C6A-197A-46BE-9CCA-3DDEC703FCB4Q33846535-BFDC7CAB-80A0-4BC2-9C78-F7E75146ACBFQ33908465-9F2F835B-BC31-4ED4-8625-17BBAC52647CQ33998879-8EDDAFAF-128A-4DD8-B12A-BDBD920B78E5Q34034676-13B036BD-A8DA-4F33-ACB0-BF2206F01EC9Q34135765-1A50EF40-9F55-4599-844C-BD4EE43A4CB3Q34476620-D644978B-FC34-4127-BBF0-09E6245F61C1Q34632548-F3289646-C073-46EC-85D0-A6C40A0F0ED0Q34929340-E6330AD7-4AFA-4C5F-B880-2C904425C50EQ35034107-CE2F9CE0-B350-4788-9DAF-F717B7C4EABBQ35034160-8B2910DE-97C6-4CDA-BEB3-193B347C4AC3Q35830110-7861552C-B789-4330-B1D2-E606BD20FB8EQ35830782-6B6CF453-5203-4097-865F-55B16A138BECQ35833873-0E60597C-CEDC-4272-A671-EBA90F37FFE8Q35874837-5CC5744B-6502-40C3-B032-5581EEE9FA3AQ36223206-1D2EBB14-CEB5-4AAE-8794-26432B19627AQ36705979-2918DE39-6AF5-4C98-9AE7-96C1BC7BB3D2Q36752763-3ADDC1B3-1ACB-4B5D-9BF6-B720264C6617Q37228532-C1592A42-95CD-4243-90AB-77B8A097F22DQ37272242-C27C9576-AA03-43E3-9F09-0A7D8502FDB9Q37488725-CF6BD6CD-5418-4796-8157-2C6A4D3A45B6Q37546757-FDADE9C5-D96F-4895-B86F-E67B82C8B823Q37548547-DFB330CA-AEED-4E78-A4D6-1CE36540C8ADQ37611617-556624E9-0FAE-415A-A12A-9DEF50D7DB75Q39797143-F1EA0F3A-97AE-4822-B99B-C70BB8D6633CQ40069672-28F15C01-33EB-404A-BE2D-301924004CBDQ40297038-165D38AA-67EC-4223-BCE0-364125C64BF1Q40641632-60A0218D-8FA8-46E3-A3E5-DD96F8B2A26AQ41760172-E678ABBE-C75D-464E-8655-F303C095DC53Q41866026-07724CFE-49D9-460E-A674-297EE5B6B1BCQ48049656-BF3BD2FC-6B3D-4FCC-A800-48A94BA494EDQ55080447-DA648866-5496-4CA6-BF78-7F427F1200CAQ58789499-E916D431-0B8B-47C0-B758-8BE9EF1B3DB2
P2860
Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells.
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Malignant transformation of mo ...... n by surrounding normal cells.
@ast
Malignant transformation of mo ...... n by surrounding normal cells.
@en
type
label
Malignant transformation of mo ...... n by surrounding normal cells.
@ast
Malignant transformation of mo ...... n by surrounding normal cells.
@en
prefLabel
Malignant transformation of mo ...... n by surrounding normal cells.
@ast
Malignant transformation of mo ...... n by surrounding normal cells.
@en
P2093
P2860
P356
P1476
Malignant transformation of mo ...... n by surrounding normal cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.17.6389
P407
P577
1988-09-01T00:00:00Z